Security key
738920107
Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share (ASBP)
CUSIP: 738920107
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 3,123,043
- Total 13F value
- $645,607
- Share change
- +1,078,739
- SEC-reported price per share
- $0.21
- Number of holders
- 25
- Value change
- +$222,104
- Number of buys
- 15
- Number of sells
- 7
- Shares outstanding
- 5,250,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
25
Top holders
10
ASBP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Aspire Biopharma Holdings, Inc. SEC filings
Aspire Biopharma Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 738920107
Recent filing periods:
Ownership snapshot
Top reported holders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lance Friedman
Disclosed value leader
Lance Friedman
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 4.5%
13D/G row: Lance Friedman
Showing 1-6 of 15 holder rows.
Quick read
Lance Friedman leads the comparable SEC ownership view at 4.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lance Friedman's linked filing trail.
Comparable ownership
Top 5
Lance Friedman
4.5%
Harraden Circle Investments, LLC
0.31%
Donald G. Fell
0.38%
Procyon Advisors, LLC
12%
Crewe Advisors LLC
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lance Friedman |
13D/G
|
4.5%
|
$1,037,706
2,207,886 shares
|
-$782,315 | 06 May 2025 |
| Harraden Circle Investments, LLC |
13D/G
|
0.31%
|
$70,500
150,000 shares
|
$0 | 31 Mar 2025 |
| Donald G. Fell |
3/4/5
Director
|
0.38%
|
$7,800
20,000 shares
|
— | 04 Jun 2025 |
| Procyon Advisors, LLC |
13F
Company
|
12%
|
$174,423
648,411 shares
|
— | 30 Jun 2025 |
| Crewe Advisors LLC |
13F
Company
|
12%
|
$168,624
626,854 shares
|
— | 30 Jun 2025 |
| Optivise Advisory Services LLC |
13F
Company
|
4.5%
|
$63,244
235,106 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
3,123,043
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
16
Q3 2025 holders
25
Holder diff
9
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend